Short-term Outcomes of Albumin-Bound Paclitaxel (Abraxane)-Containing Chemotherapy in Patients with Advanced Gastric Cancer: a Report of 14 Cases

Zheng Yan,Liangping Xia,Huijuan Qiu,Ping Chen,Bei Zhang

DOI: https://doi.org/10.1007/s10330-012-1097-3

2013-01-01

Abstract:Albumin-bound paclitaxel (abraxane, ABX) has more favorable efficacy and less toxicity than conventional taxanes. However, the data of ABX in advanced gastric cancer (AGC) treatment is unavailable. The current study was designed to summarize our experience in treating AGC patients with ABX.